Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.

Cashin PH, Mahteme H, Graf W, Karlsson H, Larsson R, Nygren P.

BMC Cancer. 2013 Sep 24;13:435. doi: 10.1186/1471-2407-13-435.

2.

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.

Bjersand K, Mahteme H, Sundström Poromaa I, Andréasson H, Graf W, Larsson R, Nygren P.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S810-6. doi: 10.1245/s10434-015-4675-0. Epub 2015 Jul 21.

3.

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP.

Ann Surg. 2006 Feb;243(2):212-22. Review.

4.

Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.

Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.

J Surg Oncol. 2013 May;107(6):585-90. doi: 10.1002/jso.23303. Epub 2012 Dec 27.

PMID:
23280508
5.

Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.

Cashin PH, Graf W, Nygren P, Mahteme H.

Eur J Surg Oncol. 2012 Jun;38(6):509-15. doi: 10.1016/j.ejso.2012.03.001. Epub 2012 Apr 3.

PMID:
22475555
6.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.

Iversen LH, Rasmussen PC, Hagemann-Madsen R, Laurberg S.

Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.

PMID:
23458368
7.

The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.

Brouquet A, Goéré D, Lefèvre JH, Bonnet S, Dumont F, Raynard B, Elias D.

Ann Surg Oncol. 2009 Oct;16(10):2744-51. doi: 10.1245/s10434-009-0611-5. Epub 2009 Jul 21.

PMID:
19626375
8.

[Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].

Königsrainer I, Beckert S, Brücher B, Zieker D, Königsrainer A.

Dtsch Med Wochenschr. 2011 Sep;136(36):1811-4. doi: 10.1055/s-0031-1286108. Epub 2011 Aug 31. German.

PMID:
21882140
9.

Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.

Klaver YL, Simkens LH, Lemmens VE, Koopman M, Teerenstra S, Bleichrodt RP, de Hingh IH, Punt CJ.

Eur J Surg Oncol. 2012 Jul;38(7):617-23. doi: 10.1016/j.ejso.2012.03.008. Epub 2012 May 8.

PMID:
22572106
10.

[Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].

Vaira M, Scuderi S, Costamagna D, Barone R, Aghemo B, Mioli PR, De Simone M.

Minerva Chir. 2002 Oct;57(5):597-605. Review. Italian.

PMID:
12370661
11.

Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.

Elias D, Benizri E, Di Pietrantonio D, Menegon P, Malka D, Raynard B.

Ann Surg Oncol. 2007 Feb;14(2):509-14. Epub 2006 Nov 10.

PMID:
17096054
12.

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.

Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.

Ann Surg Oncol. 2012 Jul;19(7):2186-94. doi: 10.1245/s10434-012-2264-z. Epub 2012 Mar 7.

PMID:
22395983
13.

Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.

Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, Rougier P, Ducreux M.

Cancer. 2001 Jul 1;92(1):71-6.

PMID:
11443611
14.

Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.

Sørensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG.

Eur J Surg Oncol. 2012 Oct;38(10):969-76. doi: 10.1016/j.ejso.2012.06.552. Epub 2012 Jul 3.

PMID:
22763244
15.

Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.

Andréasson H, Graf W, Nygren P, Glimelius B, Mahteme H.

Eur J Surg Oncol. 2012 Oct;38(10):962-8. doi: 10.1016/j.ejso.2012.07.009. Epub 2012 Jul 17.

PMID:
22809859
16.

Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy.

Hultman B, Mahteme H, Sundbom M, Ljungman M, Larsson R, Nygren P.

J Exp Clin Cancer Res. 2014 Dec 21;33:110. doi: 10.1186/s13046-014-0110-9.

17.

Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis.

Mahteme H, von Heideman A, Grundmark B, Tholander B, Påhlman L, Glimelius B, Larsson R, Graf W, Nygren P.

Eur J Surg Oncol. 2008 May;34(5):547-52. Epub 2007 Jun 18.

PMID:
17574369
18.

Surgery and intracavitary chemotherapy for peritoneal carcinomatosis from colorectal origin.

Ceelen W, Van Nieuwenhove Y, Pattyn P.

Acta Gastroenterol Belg. 2008 Oct-Dec;71(4):373-8. Review.

PMID:
19317277
19.

Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.

Chua TC, Liauw W, Saxena A, Al-Mohaimeed K, Fransi S, Zhao J, Morris DL.

Am J Surg. 2011 Feb;201(2):149-56. doi: 10.1016/j.amjsurg.2010.02.012. Epub 2010 Sep 15.

PMID:
20832051
20.

Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience.

Nikolic S, Dzodic R, Zegarac M, Djurisic I, Gavrilovic D, Vojinovic V, Kocic M, Santrac N, Radlovic P, Radosavljevic D, Pupic G, Martinovic A.

J BUON. 2014 Jan-Mar;19(1):66-74.

PMID:
24659645

Supplemental Content

Support Center